Cargando…

Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer

Renal cell carcinoma (RCC) is a biologically heterogeneous disease, with many small renal masses (SRMs) exhibiting an indolent natural history, while others progress more rapidly to become life-threatening. Existing multiphase contrast-enhanced imaging methods, such as computed tomography or magneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smaldone, Marc C, Chen, David YT, Yu, Jian Q, Plimack, Elizabeth R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508606/ https://www.ncbi.nlm.nih.gov/pubmed/23204838 http://dx.doi.org/10.2147/BTT.S30413

Ejemplares similares

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
por: Basaco, Tais, et al.
Publicado: (2018)

Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with (111)In-girentuximab
por: van Oostenbrugge, Tim J., et al.
Publicado: (2019)

Phase I study to assess safety, biodistribution and radiation dosimetry for (89)Zr-girentuximab in patients with renal cell carcinoma
por: Merkx, Robin I. J., et al.
Publicado: (2021)

[(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2023)

A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib
por: Suzuki, Issei, et al.
Publicado: (2021)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2015)

STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC
por: Hasanov, Elshad, et al.
Publicado: (2023)

Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2019)

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Presurgical Pulmonary Evaluation in Renal Transplant Patients
por: Sahni, Sonu, et al.
Publicado: (2014)

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
por: Koie, Takuya, et al.
Publicado: (2013)

Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review
por: McCormick, Barrett, et al.
Publicado: (2017)

Robotic renal surgery for renal cell carcinoma with inferior vena cava thrombus
por: Masic, Selma, et al.
Publicado: (2021)

Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava
por: Uematsu, Toshitaka, et al.
Publicado: (2022)

Neoadjuvant/presurgical treatments
por: Smith, Ian E
Publicado: (2008)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

Who benefits from presurgical endoscopic diagnosis: the patient or the surgeon?
por: Hassan, Cesare, et al.
Publicado: (2019)

Clear Cell Papillary Renal Cell Carcinoma: A Potential Mimic of Conventional Clear Cell Renal Carcinoma on Core Biopsy
por: Liddell, Heath, et al.
Publicado: (2015)

(89)Zirconium-labelled girentuximab ((89)Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma
por: Al-Zubaidi, Mohammed, et al.
Publicado: (2022)

Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus
por: Peng, Cheng, et al.
Publicado: (2018)

Ovarian Dysgerminoma – Challenging Presurgical Diagnosis and Mini-Mally Invasive Treatment
por: Otto, K, et al.
Publicado: (2023)

Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma
por: Cochetti, Giovanni, et al.
Publicado: (2020)

Connectome the Dots for Presurgical Predictions
por: Lillis, Kyle P.
Publicado: (2022)

Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma
por: Wang, Zengzeng, et al.
Publicado: (2018)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

Single cell analysis reveals intra‐tumour heterogeneity, microenvironment and potential diagnosis markers for clear cell renal cell carcinoma
por: Zhang, Man, et al.
Publicado: (2022)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
por: Knochelmann, Hannah M., et al.
Publicado: (2021)

Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis
por: Somorácz, Áron, et al.
Publicado: (2019)

Annexin II represents metastatic potential in clear-cell renal cell carcinoma
por: Ohno, Y, et al.
Publicado: (2009)

Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma
por: Yang, Juan, et al.
Publicado: (2014)

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients
por: Zhang, Tian, et al.
Publicado: (2020)

Oncogenic potential of macrophage-capping protein in clear cell renal cell carcinoma
por: Chen, Zhuang-Fei, et al.
Publicado: (2021)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas
por: Shih, Andrew J., et al.
Publicado: (2020)

Short-term presurgical treatment for all?
por: Dowsett, Mitch, et al.
Publicado: (2007)

Role of Neuroimaging in the Presurgical Evaluation of Epilepsy
por: Wehner, Tim, et al.
Publicado: (2008)

Presurgical epilepsy evaluation and epilepsy surgery
por: Baumgartner, Christoph, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m9ukjdr1us7b1pa95remlitaau